| Literature DB >> 33790343 |
Alfredo Raglio1, Monica Panigazzi2, Roberto Colombo2, Marco Tramontano3, Marco Iosa3, Sara Mastrogiacomo3, Paola Baiardi2, Daniele Molteni2, Eleonora Baldissarro4, Chiara Imbriani2, Chiara Imarisio2, Laura Eretti5, Mehrnaz Hamedani6, Caterina Pistarini4, Marcello Imbriani2, Gian Luigi Mancardi6, Carlo Caltagirone3.
Abstract
After a stroke event, most survivors suffer from arm paresis, poor motor control and other disabilities that make activities of daily living difficult, severely affecting quality of life and personal independence. This randomized controlled trial aimed at evaluating the efficacy of a music-based sonification approach on upper limbs motor functions, quality of life and pain perceived during rehabilitation. The study involved 65 subacute stroke individuals during inpatient rehabilitation allocated into 2 groups which underwent usual care dayweek) respectively of standard upper extremity motor rehabilitation or upper extremity treatment with sonification techniques. The Fugl-Meyer Upper Extremity Scale, Box and Block Test and the Modified Ashworth Scale were used to perform motor assessment and the McGill Quality of Life-it and the Numerical Pain Rating Scale to assess quality of life and pain. The assessment was performed at baseline, after 2 weeks, at the end of treatment and at follow-up (1 month after the end of treatment). Total scores of the Fugl-Meyer Upper Extremity Scale (primary outcome measure) and hand and wrist sub scores, manual dexterity scores of the affected and unaffected limb in the Box and Block Test, pain scores of the Numerical Pain Rating Scale (secondary outcomes measures) significantly improved in the sonification group compared to the standard of care group (time*group interaction < 0.05). Our findings suggest that music-based sonification sessions can be considered an effective standardized intervention for the upper limb in subacute stroke rehabilitation.Entities:
Year: 2021 PMID: 33790343 PMCID: PMC8012636 DOI: 10.1038/s41598-021-86627-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline clinical characteristics of patients in Sonification Group (SG) and Standard of Care Group (SoCG).
| SG (n = 33) | SoCG (n = 32) | p | |
|---|---|---|---|
| Mean ± SD or N (%) | Mean ± SD or N (%) | ||
| Sex (males/females) | 17 (51.5%) /16 (48.5%) | 18 (56.2%) /14 (46.8%) | 0.70a |
| Age (years) | 62.4 ± 8.9 | 64.7 ± 16.0 | 0.52b |
| Handedness (right handed) | 31 (93.9%) | 31 (93.8%) | 0.97a |
| 0.68c | |||
| Median | 34.5 | 29.5 | |
| Interquartile Range | 38.25 | 31.75 | |
| Min–Max | 12–180 | 13–180 | |
| 0.063a | |||
| Right | 22 (66.7) | 14(43.8) | |
| Left | 11 (33.3) | 18 (56.3) | |
aChi-square test; bStudent’s t test; cMann–Whitney U Test.
Figure 1The flow chart of the study. All randomized patients received the allocated intervention. Between baseline and the 4-week evaluation two patients in the Sonification group discontinued the treatment. No discontinuation occurred in the Standard Care Group. After 1 month from the beginning of treatment (T3 follow-up) 18 and 16 patients were lost to follow-up in the Sonification and Standard Care Groups, respectively. The primary analysis (T2, end of the 4-week treatment) was performed on the Intention To Treat (ITT) and Per Protocol (PP) populations, with the numbers reported in the figure.
Upper extremity scores (primary and secondary outcomes) at T0 and T2 (intention to treat analysis).
| SG (n = 33) | SoCG (n = 32) | Time*group interaction | Effect size | Time effect | Effect size | Group effect | Effect size | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F | df | p value | F | df | p value | F | df | p value | ||||||
| FM-UE Total score | ||||||||||||||
| T0 | 39.58 ± 10.99 | 39.19 ± 14.94 | 5.326 | 1 | 0.078 | 136.93 | 1 | 0.685 | 0.665 | 1 | 0.418 | 0.010 | ||
| T2 | 53.70 ± 12.03 | 48.66 ± 17.37 | ||||||||||||
| FM-UE proximal score | ||||||||||||||
| T0 | 22.27 ± 6.49 | 21.31 ± 9.09 | 1.424 | 1 | 0.237 | 0.022 | 99.56 | 1 | 0.612 | 0.884 | 1 | 0.350 | 0.014 | |
| T2 | 29.89 ± 6.23 | 27.31 ± 9.92 | ||||||||||||
| FM-UE distal score | ||||||||||||||
| T0 | 13.88 ± 4.81 | 14.12 ± 6.68 | 6.072 | 1 | 0.088 | 110.97 | 1 | 0.638 | 0.376 | 1 | 0.542 | 0.006 | ||
| T2 | 19.82 ± 4.59 | 17.81 ± 7.71 | ||||||||||||
| FM-UE wrist score | ||||||||||||||
| T0 | 5.55 ± 2.11 | 5.78 ± 2.81 | 4.778 | 1 | 0.071 | 75.06 | 1 | 0.544 | 0.138 | 1 | 0.711 | 0.002 | ||
| T2 | 7.85 ± 2.09 | 7.16 ± 3.29 | ||||||||||||
| FM-UE hand score | ||||||||||||||
| T0 | 8.33 ± 3.30 | 8.34 ± 4.13 | 4.391 | 1 | 0.065 | 88.67 | 1 | 0.585 | 0.538 | 1 | 0.466 | 0.008 | ||
| T2 | 11.97 ± 2.98 | 10.66 ± 4.60 | ||||||||||||
| BBT affected limb | ||||||||||||||
| T0 | 13.39 ± 9.24 | 16.50 ± 14.27 | 5.657 | 1 | 0.082 | 87.65 | 1 | 0.582 | 0.137 | 1 | 0.712 | 0.002 | ||
| T2 | 23.06 ± 10.80 | 22.25 ± 16.32 | ||||||||||||
| BBT unaffected limb | ||||||||||||||
| T0 | 32.12 ± 9.94 | 30.56 ± 12.06 | 8.873 | 1 | 0.123 | 42.87 | 1 | 0.405 | 2.530 | 1 | 0.117 | 0.039 | ||
| T2 | 39.88 ± 9.63 | 33.47 ± 10.72 | ||||||||||||
| BBT ratio | ||||||||||||||
| T0 | 0.42 ± 0.25 | 0.58 ± 0.55 | 1.787 | 1 | 0.186 | 0.028 | 17.581 | 1 | 0.218 | 1.887 | 1 | 0.174 | 0.029 | |
| T2 | 0.57 ± 0.22 | 0.66 ± 0.45 | ||||||||||||
| NPRS | ||||||||||||||
| T0 | 3.79 ± 3.02 | 1.76 ± 2.44 | 7.972 | 1 | 0.006 | 0.112 | 12.46 | 1 | 0.001 | 0.165 | 4.120 | 1 | 0.047 | 0.061 |
| T2 | 1.65 ± 2.23 | 1.52 ± 2.34 | ||||||||||||
| MAS Wrist (a) | ||||||||||||||
| T0 | 0 (1) | 0 (1) | 2.46 | 1 | 0.117 | – | 97.0 | 1 | 0.186 | – | 0.302 | 1 | 0.583 | – |
| T2 | 0 (1) | 0 (1) | ||||||||||||
| MAS fingers (a) | ||||||||||||||
| T0 | 0 (1) | 0 (1) | 2.534 | 1 | 0.111 | – | 13.5 | 1 | – | 0.391 | 1 | 0.532 | – | |
| T2 | 0 (0.5) | 0 (0.75) | ||||||||||||
| MQoL-it | ||||||||||||||
| T0 | 6.60 ± 1.41 | 6.89 ± 1.32 | 0.495 | 1 | 0.484 | 0.008 | 13.56 | 1 | 0.177 | 0.373 | 1 | 0.543 | 0.006 | |
| T2 | 7.32 ± 1.34 | 7.37 ± 1.06 | ||||||||||||
Values for continuous variables are reported as mean ± standard deviation, those for categorical data are reported as median and interquartile range.
SG Sonification Group, SoCG Standard of Care Group, FM-UE Fugl-Meyer Upper Extremity scale, BBT Box and Block Test, NPRS Numerical Pain Rating Scale, MAS Modified Ashworth Scale, MQoL-it McGill Quality of Life (Italian Version) , df degrees of freedom; (a) = non-parametric (Kruskall-Wallis) statistics.
Figure 2Trend between baseline (T0) and end of treatment (T2, 4 weeks) of primary outcome, FM-UE Total Score.
Figure 3Trend between baseline (T0) and end of treatment (T2, 4 weeks) of secondary outcomes.